Palisade Bio Net Debt Growth & History (PALI)

Palisade Bio's net debt was −$133.4M for fiscal 2025.

View full Palisade Bio company overview

Palisade Bio annual net debt history

Palisade Bio annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$133.4M−$123.7M
20242024-12-31−$9.7M$2.5M
20232023-12-31−$12.2M−$154,000
20222022-12-31−$12.1M−$1.8M
20212021-12-31−$10.3M−$11.0M
20202020-12-31$708,000$5.7M
20192019-12-31−$5.0M
20162016-12-31−$11.5M−$14.7M
20152015-12-31$3.2M$6.9M
20142014-12-31−$3.7M$5.4M
20132013-12-31−$9.1M−$1.7M
20122012-12-31−$7.4M

Palisade Bio net debt trends

Over the last five fiscal years, Palisade Bio's net debt decreased from $708,000 to −$133.4M, a change of −$134.1M. The latest reported quarter, Q2 2026, shows −$125.2M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Palisade Bio source filings ↗

Community posts

It’s quiet here.

No posts about PALI yet. Start the conversation.

Write the first post